N

Novoray Corp
SSE:688300

Watchlist Manager
Novoray Corp
SSE:688300
Watchlist
Price: 65.4 CNY 0.09% Market Closed
Market Cap: 12.1B CNY
Have any thoughts about
Novoray Corp?
Write Note

Novoray Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novoray Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
Novoray Corp
SSE:688300
Operating Income
ÂĄ179.5m
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Zhejiang Juhua Co Ltd
SSE:600160
Operating Income
ÂĄ1.8B
CAGR 3-Years
81%
CAGR 5-Years
3%
CAGR 10-Years
27%
Hengli Petrochemical Co Ltd
SSE:600346
Operating Income
ÂĄ13.4B
CAGR 3-Years
-19%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Satellite Chemical Co Ltd
SZSE:002648
Operating Income
ÂĄ7.4B
CAGR 3-Years
7%
CAGR 5-Years
36%
CAGR 10-Years
31%
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
Operating Income
ÂĄ52.9m
CAGR 3-Years
-78%
CAGR 5-Years
-51%
CAGR 10-Years
-14%
Rongsheng Petrochemical Co Ltd
SZSE:002493
Operating Income
ÂĄ12.1B
CAGR 3-Years
-25%
CAGR 5-Years
38%
CAGR 10-Years
39%
No Stocks Found

Novoray Corp
Glance View

Market Cap
12.1B CNY
Industry
Chemicals

In the bustling landscape of modern technology companies, Novoray Corp has carved out a niche with its cutting-edge solutions in the realm of imaging and radiography technology. Founded by a group of visionary engineers and entrepreneurs, Novoray emerged from the need to innovate within medical and industrial sectors. The company has honed its expertise in developing advanced imaging systems that harness the power of digital radiography and computed tomography. These systems find applications in diverse fields ranging from healthcare diagnostics to industrial non-destructive testing, offering unparalleled clarity and precision. Novoray's commitment to research and development is evident in its consistently innovative product lineup, attracting a loyal clientele composed of hospitals, manufacturing units, and research institutions worldwide. At the heart of Novoray's business model lies its multi-faceted revenue streams. The company generates income by selling state-of-the-art imaging equipment, complemented by service contracts for maintenance and upgrades, ensuring clients have continuous access to the latest technology. Beyond hardware sales, Novoray has strategically boosted its recurring revenue through software solutions that enhance image processing and diagnostics. This software-as-a-service (SaaS) approach facilitates smooth integration into clients' existing systems, driving efficiency and improving outcomes. Additionally, Novoray capitalizes on training and consultancy services, empowering clients to leverage their technology to its full potential. Through these various avenues, Novoray Corp not only sustains its financial health but also secures a reputation as a leader in precision imaging solutions.

Intrinsic Value
46.11 CNY
Overvaluation 30%
Intrinsic Value
Price
N

See Also

What is Novoray Corp's Operating Income?
Operating Income
179.5m CNY

Based on the financial report for Dec 31, 2023, Novoray Corp's Operating Income amounts to 179.5m CNY.

What is Novoray Corp's Operating Income growth rate?
Operating Income CAGR 5Y
21%

Over the last year, the Operating Income growth was 3%. The average annual Operating Income growth rates for Novoray Corp have been 18% over the past three years , 21% over the past five years .

Back to Top